Risk Analysis of Systemic Levels of Estrogen and Adipokines As Well As Estrogen Receptors from PBMCs in Childbearing and Perimenopausal Women with Obesity

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2019 Sep 20

PMID 31534355

Citations 5

Authors

Huijuan Fan

Shujiao Chen

Bizhen Gao

Shanshan Ding

Qiang Zhao

Candong Li

Tetsuya Asakawa

Affiliations

Soon will be listed here.

Abstract

Purpose: We aimed to evaluate the clinical value of systemic levels of estrogen and adipokines as well as estrogen receptors from peripheral blood mononuclear cells (PBMCs) in childbearing and perimenopausal women with obesity.

Subjects And Methods: We observed 292 women, including 160 perimenopausal women (80 with obesity and 80 without obesity) and 132 women of childbearing age (67 with obesity and 65 without obesity). Body parameters, such as body mass index and waist circumference, were measured. Fat distribution was evaluated using a computerized tomography scanner. The levels of serum estrogen, leptin, visfatin, and adiponectin were measured using an enzyme-linked immunosorbent assay. The expression of circulating ERs was evaluated by Western blot analysis.

Results: Perimenopausal women and childbearing women with obesity exhibited lower levels of estrogen and adiponectin, in addition to a distribution of visceral fat with higher levels of leptin and visfatin. These findings reflect the current data of menopausal women, which confirms the reliability of this experimental system. However, the expression of ERα in peripheral blood was significantly enhanced in women with obesity of both childbearing and perimenopausal age. This result is contrary to the common understanding of adipose tissue, namely that ERα is protective. The expression of ERβ in the women without obesity of both childbearing and perimenopausal age was higher than in women with obesity, which coincides with the results of a previous study on adipose tissue.

Conclusion: Our data fundamentally contradicts the utility of circulating ERα and ERα/ERβ evaluations in obesity studies. Because estrogen exerts pleiotropic effects on multiple tissues in the body through differential regulation of ERs, although the expression of ERβ coincides with the results of a previous study on adipose tissue, the expression levels of ERs in blood cannot be used as a diagnostic of informative tool for obesity in women.

Citing Articles

Adiponectin and Adiponectin Receptors in Atherosclerosis.

Gianopoulos I, Mantzoros C, Daskalopoulou S Endocr Rev. 2024; 46(1):1-25.

PMID: 39106421 PMC: 11720176. DOI: 10.1210/endrev/bnae021.

A Drosophila model targets Eiger/TNFα to alleviate obesity-related insulin resistance and macrophage infiltration.

Mirzoyan Z, Valenza A, Zola S, Bonfanti C, Arnaboldi L, Ferrari N Dis Model Mech. 2023; 16(11.

PMID: 37828911 PMC: 10651092. DOI: 10.1242/dmm.050388.

Obesity and Thyroid Cancer Risk: An Update.

Franchini F, Palatucci G, Colao A, Ungaro P, Macchia P, Nettore I Int J Environ Res Public Health. 2022; 19(3).

PMID: 35162142 PMC: 8834607. DOI: 10.3390/ijerph19031116.

Serum Metabolic Profiles of Chinese Women With Perimenopausal Obesity Explored by the Untargeted Metabolomics Approach.

Ding S, Chen M, Liao Y, Chen Q, Lin X, Chen S Front Endocrinol (Lausanne). 2021; 12:637317.

PMID: 34630316 PMC: 8498571. DOI: 10.3389/fendo.2021.637317.

Correlation between physical activity and cardiovascular risk factors in postmenopausal women from Colombia Caribbean.

Rebolledo-Cobos R, Becerra J, Sanchez L, Mendinueta-Martinez M, Polo-Gallardo R, Sarmiento-Rubiano M Porto Biomed J. 2021; 6(1):e118.

PMID: 33532659 PMC: 7846413. DOI: 10.1097/j.pbj.0000000000000118.

References

Elbers J, de Jong S, Teerlink T, Asscheman H, Seidell J, Gooren L . Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism. 1999; 48(11):1371-7. DOI: 10.1016/s0026-0495(99)90146-4. View

Toth M, Poehlman E, Matthews D, Tchernof A, MacCoss M . Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats. Am J Physiol Endocrinol Metab. 2001; 280(3):E496-501. DOI: 10.1152/ajpendo.2001.280.3.E496. View

Garaulet M, Perez-Llamas F, Baraza J, Garcia-Prieto M, Fardy P, Tebar F . Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J Nutr Health Aging. 2002; 6(2):123-6. View

Chen C, Lu F . The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2005; 17 Suppl:1-36. View

Woods N, Mitchell E . Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med. 2006; 118 Suppl 12B:14-24. DOI: 10.1016/j.amjmed.2005.09.031. View

Mastorakos G, Valsamakis G, Papatheodorou D, Barlas I, Margeli A, Boutsiadis A . The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007; 53(8):1477-83. DOI: 10.1373/clinchem.2006.084731. View

Plati E, Kouskouni E, Malamitsi-Puchner A, Boutsikou M, Kaparos G, Baka S . Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril. 2009; 94(4):1451-1456. DOI: 10.1016/j.fertnstert.2009.04.055. View

Liu S, Mauvais-Jarvis F . Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology. 2009; 151(3):859-64. PMC: 2840685. DOI: 10.1210/en.2009-1107. View

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

10.

Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M . Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2010; 44(1):82-92. DOI: 10.3109/07853890.2010.526138. View

11.

Park C, Zhao Z, Glidewell-Kenney C, Lazic M, Chambon P, Krust A . Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest. 2011; 121(2):604-12. PMC: 3026715. DOI: 10.1172/JCI41702. View

12.

Shi H, Senthil Kumar S, Liu X . G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci. 2013; 114:193-250. PMC: 3632385. DOI: 10.1016/B978-0-12-386933-3.00006-6. View

13.

Chen S, Asakawa T, Ding S, Liao L, Zhang L, Shen J . Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats. PLoS One. 2013; 8(8):e72428. PMC: 3754981. DOI: 10.1371/journal.pone.0072428. View

14.

Zhu L, Martinez M, Emfinger C, Palmisano B, Stafford J . Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am J Physiol Endocrinol Metab. 2014; 306(10):E1188-97. PMC: 4116406. DOI: 10.1152/ajpendo.00579.2013. View

15.

Arnoldussen I, Kiliaan A, Gustafson D . Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol. 2014; 24(12):1982-99. PMC: 4169761. DOI: 10.1016/j.euroneuro.2014.03.002. View

16.

Jung U, Choi M . Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15(4):6184-223. PMC: 4013623. DOI: 10.3390/ijms15046184. View

17.

Lizcano F, Guzman G . Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int. 2014; 2014:757461. PMC: 3964739. DOI: 10.1155/2014/757461. View

18.

Grantham J, Henneberg M . The estrogen hypothesis of obesity. PLoS One. 2014; 9(6):e99776. PMC: 4051760. DOI: 10.1371/journal.pone.0099776. View

19.

Chedraui P, Perez-Lopez F, Escobar G, Palla G, Montt-Guevara M, Cecchi E . Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014; 79(1):86-90. DOI: 10.1016/j.maturitas.2014.06.008. View

20.

Kural B, Deger O, Erem C, Balaban Yucesan F, Aliyazicioglu R, Barlak Y . Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome?. Turk J Med Sci. 2015; 44(6):1021-8. DOI: 10.3906/sag-1310-90. View